Sunny Kaul, BSc, MBChB, PHD, FRCP, FFICM

Royal Brompton & Harefield NHS Foundation Trust, United Kingdom

Disclosure(s): Chiesi: Speaker fees; Gilead: Speaker fees; GlaxoSmithKline: Speaker fees; MSD: Grant/Research Support, Speaker fees; Shionogi: Speaker fees; Vifor Pharma: Grant/Research Support

Poster(s):

• 673 - Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA): Results from a multi-national, multicenter observational study
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET